Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced/Metastatic Solid Tumours”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT05948865
What this trial is testing

CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
CancerCancer, Lung
Conjupro Biotherapeutics, Inc. 132
Early research (Phase 1)Not Yet RecruitingNCT07558200
What this trial is testing

Phase Ia/Ib Study of FXB0871 Monotherapy in Locally Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorsNon-Small Cell Lung CancerHepatocellular Carcinoma
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. 138
Early research (Phase 1)Active Not RecruitingNCT05598151
What this trial is testing

Dose Escalation and Expansion Study of HM97662 in Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumors
Hanmi Pharmaceutical Company Limited 170
Testing effectiveness (Phase 2)Active Not RecruitingNCT05438329
What this trial is testing

First-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumor
DualityBio Inc. 1,123
Early research (Phase 1)Study completedNCT01673737
What this trial is testing

A Phase I/Ib Trial for the Evaluation of SAR260301 in Monotherapy or in Combination With Vemurafenib in Patients With Various Advanced Cancer

Who this might be right for
Neoplasm Malignant
Sanofi 75
Early research (Phase 1)Study completedNCT04252339
What this trial is testing

RLY-1971 in Subjects With Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumor, Unspecified, Adult
Hoffmann-La Roche 56
Testing effectiveness (Phase 2)Active Not RecruitingNCT04266912
What this trial is testing

Avelumab and M6620 for the Treatment of DDR Deficient Metastatic or Unresectable Solid Tumors

Who this might be right for
Metastatic Malignant Solid NeoplasmRefractory Malignant Solid NeoplasmUnresectable Malignant Solid Neoplasm
M.D. Anderson Cancer Center 23
Early research (Phase 1)Study completedNCT05479812
What this trial is testing

Dose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors

Who this might be right for
Metastatic Solid TumorAdvanced Solid Tumor
Werewolf Therapeutics, Inc. 156
Early research (Phase 1)Study completedNCT04196283
What this trial is testing

Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-368 Plus Tilsotolimod and Other Therapy Combinations in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Advanced Solid Tumors Cancer
AbbVie 30
Early research (Phase 1)Study completedNCT02045602
What this trial is testing

Phase I Dose Escalation Study of Intravenous VCN-01 With or Without Gemcitabine and Abraxane® in Patients With Advanced Solid Tumors

Who this might be right for
Locally Advanced Solid TumorsMetastatic Solid TumorsPancreatic Adenocarcinoma
Theriva Biologics SL 42
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07307053
What this trial is testing

Rare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2)

Who this might be right for
Rare Malignant NeoplasmAdvanced Solid TumorsMetastatic Solid Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 600
Early research (Phase 1)Active Not RecruitingNCT06328439
What this trial is testing

Evaluate ANS014004 in Subjects With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumors
Avistone Biotechnology Co., Ltd. 40
Testing effectiveness (Phase 2)Looking for participantsNCT07030257
What this trial is testing

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumor MalignanciesColorectal CarcinomaSmall Cell Lung Cancer ( SCLC )+4 more
Tasca Therapeutics 150
Not applicableLooking for participantsNCT04515810
What this trial is testing

Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning

Who this might be right for
Locally Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmRecurrent Hematologic Malignancy+1 more
Fred Hutchinson Cancer Center 400
Early research (Phase 1)Looking for participantsNCT05859074
What this trial is testing

MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

Who this might be right for
Cutaneous Squamous Cell CarcinomaSCC - Squamous Cell CarcinomaBasal Cell Carcinoma+16 more
Memorial Sloan Kettering Cancer Center 56
Early research (Phase 1)Study completedNCT02097810
What this trial is testing

Study of Oral RXDX-101 in Adult Patients With Locally Advanced or Metastatic Cancer Targeting NTRK1, NTRK2, NTRK3, ROS1, or ALK Molecular Alterations.

Who this might be right for
Locally Advanced Solid TumorsMetastatic Solid Tumors
Hoffmann-La Roche 84
Testing effectiveness (Phase 2)Looking for participantsNCT05592626
What this trial is testing

A Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsGenital Neoplasm, FemaleUrogenital Neoplasms+11 more
Marengo Therapeutics, Inc. 366
Early research (Phase 1)Ended earlyNCT02757391
What this trial is testing

CD8+ T Cell Therapy and Pembrolizumab in Treating Patients With Metastatic Gastrointestinal Tumors

Who this might be right for
Colorectal AdenocarcinomaMetastatic CholangiocarcinomaMetastatic Colorectal Carcinoma+10 more
M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT06083662
What this trial is testing

Neratinib and Trastuzumab Biosimilar in Patients with HER2 Mutated Advanced Solid Cancers

Who this might be right for
Metastatic CancerHER2 Gene Mutation
Korea University Guro Hospital 42
Early research (Phase 1)Study completedNCT01938846
What this trial is testing

BI 860585 Dose Escalation Single Agent and in Combination With Exemestane or With Paclitaxel in Patients With Various Advanced and/or Metastatic Solid Tumors

Who this might be right for
Neoplasms
Boehringer Ingelheim 90
Next Page